

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.08364725 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.08364725 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75388196 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.71831670 |
| 5 | CENP-A containing nucleosome assembly (GO:0034080) | 4.46961161 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43905497 |
| 7 | chromatin remodeling at centromere (GO:0031055) | 4.42348202 |
| 8 | rRNA modification (GO:0000154) | 4.34174772 |
| 9 | cellular response to zinc ion (GO:0071294) | 4.26554172 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.25131951 |
| 11 | DNA replication checkpoint (GO:0000076) | 4.15193885 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.10608371 |
| 13 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.06348024 |
| 14 | DNA strand elongation (GO:0022616) | 4.03151383 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 4.01718438 |
| 16 | establishment of integrated proviral latency (GO:0075713) | 3.92760853 |
| 17 | histone exchange (GO:0043486) | 3.87186970 |
| 18 | purine nucleobase biosynthetic process (GO:0009113) | 3.86774360 |
| 19 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.82296336 |
| 20 | hyperosmotic salinity response (GO:0042538) | 3.78187561 |
| 21 | respiratory burst (GO:0045730) | 3.77436035 |
| 22 | natural killer cell mediated immunity (GO:0002228) | 3.75666543 |
| 23 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.75666543 |
| 24 | type I interferon signaling pathway (GO:0060337) | 3.75082967 |
| 25 | cellular response to type I interferon (GO:0071357) | 3.75082967 |
| 26 | response to type I interferon (GO:0034340) | 3.73812274 |
| 27 | IMP biosynthetic process (GO:0006188) | 3.72604335 |
| 28 | regulation of RIG-I signaling pathway (GO:0039535) | 3.72405236 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.70976605 |
| 30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.69508921 |
| 31 | rRNA methylation (GO:0031167) | 3.69226049 |
| 32 | response to peptidoglycan (GO:0032494) | 3.69164610 |
| 33 | mitotic metaphase plate congression (GO:0007080) | 3.66295796 |
| 34 | L-serine metabolic process (GO:0006563) | 3.65729614 |
| 35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.65193492 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.63983068 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.62939044 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.61271208 |
| 39 | reactive oxygen species biosynthetic process (GO:1903409) | 3.58756110 |
| 40 | nucleobase biosynthetic process (GO:0046112) | 3.57973231 |
| 41 | protein localization to kinetochore (GO:0034501) | 3.56197770 |
| 42 | T-helper 1 type immune response (GO:0042088) | 3.54997067 |
| 43 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.53477476 |
| 44 | regulation of activation of Janus kinase activity (GO:0010533) | 3.52953518 |
| 45 | DNA replication-independent nucleosome organization (GO:0034724) | 3.52654609 |
| 46 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.52654609 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.49198402 |
| 48 | DNA ligation (GO:0006266) | 3.47656959 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46201888 |
| 50 | DNA strand renaturation (GO:0000733) | 3.44882157 |
| 51 | neutrophil activation (GO:0042119) | 3.44343191 |
| 52 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.42156438 |
| 53 | regulation of mitochondrial translation (GO:0070129) | 3.39978690 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.39157412 |
| 55 | base-excision repair, AP site formation (GO:0006285) | 3.38793041 |
| 56 | granulocyte activation (GO:0036230) | 3.38096428 |
| 57 | chaperone-mediated protein transport (GO:0072321) | 3.37178005 |
| 58 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.36949678 |
| 59 | viral transcription (GO:0019083) | 3.36528041 |
| 60 | translational termination (GO:0006415) | 3.35626594 |
| 61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.33571130 |
| 62 | peptidyl-histidine modification (GO:0018202) | 3.32111123 |
| 63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30572149 |
| 64 | amyloid precursor protein catabolic process (GO:0042987) | 3.29691489 |
| 65 | base-excision repair (GO:0006284) | 3.28397236 |
| 66 | mitotic sister chromatid segregation (GO:0000070) | 3.27721610 |
| 67 | proteasome assembly (GO:0043248) | 3.27388245 |
| 68 | negative regulation of ligase activity (GO:0051352) | 3.27380527 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.27380527 |
| 70 | ribosomal small subunit biogenesis (GO:0042274) | 3.26345711 |
| 71 | leukocyte mediated cytotoxicity (GO:0001909) | 3.25472529 |
| 72 | ribosome assembly (GO:0042255) | 3.24605215 |
| 73 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.23902071 |
| 74 | ribosomal large subunit biogenesis (GO:0042273) | 3.22403081 |
| 75 | mitotic recombination (GO:0006312) | 3.21442709 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 3.20626401 |
| 77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.20626401 |
| 78 | telomere maintenance via recombination (GO:0000722) | 3.18868110 |
| 79 | regulation of helicase activity (GO:0051095) | 3.15727890 |
| 80 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.15021107 |
| 81 | negative regulation of chromosome segregation (GO:0051985) | 3.14766640 |
| 82 | establishment of viral latency (GO:0019043) | 3.12810629 |
| 83 | telomere maintenance via telomere lengthening (GO:0010833) | 3.11839889 |
| 84 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.11452884 |
| 85 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.11452884 |
| 86 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.11452884 |
| 87 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.11452884 |
| 88 | negative regulation of sister chromatid segregation (GO:0033046) | 3.11452884 |
| 89 | formation of translation preinitiation complex (GO:0001731) | 3.09133588 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05614599 |
| 91 | superoxide anion generation (GO:0042554) | 3.04396098 |
| 92 | IMP metabolic process (GO:0046040) | 3.04200986 |
| 93 | pseudouridine synthesis (GO:0001522) | 3.03662276 |
| 94 | metaphase plate congression (GO:0051310) | 3.03309007 |
| 95 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.00811454 |
| 96 | defense response to protozoan (GO:0042832) | 2.99534420 |
| 97 | kinetochore assembly (GO:0051382) | 2.99163890 |
| 98 | regulation of antigen processing and presentation (GO:0002577) | 2.98983322 |
| 99 | translational elongation (GO:0006414) | 2.97955300 |
| 100 | response to interferon-alpha (GO:0035455) | 2.97904283 |
| 101 | spindle checkpoint (GO:0031577) | 2.97491378 |
| 102 | translational initiation (GO:0006413) | 2.97405877 |
| 103 | mitotic spindle checkpoint (GO:0071174) | 2.97009983 |
| 104 | cellular response to interferon-beta (GO:0035458) | 2.96450452 |
| 105 | spliceosomal snRNP assembly (GO:0000387) | 2.95504990 |
| 106 | positive regulation of B cell differentiation (GO:0045579) | 2.95323903 |
| 107 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.94696571 |
| 108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94605527 |
| 109 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.94422676 |
| 110 | termination of RNA polymerase III transcription (GO:0006386) | 2.94422676 |
| 111 | DNA replication initiation (GO:0006270) | 2.94307991 |
| 112 | kinetochore organization (GO:0051383) | 2.93747763 |
| 113 | mitotic nuclear envelope disassembly (GO:0007077) | 2.93647393 |
| 114 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.93611775 |
| 115 | response to interferon-beta (GO:0035456) | 2.93185954 |
| 116 | regulation of natural killer cell differentiation (GO:0032823) | 2.91503325 |
| 117 | protein localization to chromosome, centromeric region (GO:0071459) | 2.91134269 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90956938 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 2.90156761 |
| 120 | negative regulation of growth of symbiont in host (GO:0044130) | 2.88878060 |
| 121 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.88878060 |
| 122 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.88878060 |
| 123 | regulation of growth of symbiont in host (GO:0044126) | 2.88878060 |
| 124 | negative regulation of viral genome replication (GO:0045071) | 2.88294224 |
| 125 | mitotic spindle assembly checkpoint (GO:0007094) | 2.88207344 |
| 126 | cellular response to exogenous dsRNA (GO:0071360) | 2.87894724 |
| 127 | DNA unwinding involved in DNA replication (GO:0006268) | 2.87877056 |
| 128 | cotranslational protein targeting to membrane (GO:0006613) | 2.87841407 |
| 129 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.86736350 |
| 130 | B cell mediated immunity (GO:0019724) | 2.86184204 |
| 131 | negative regulation of mitosis (GO:0045839) | 2.85963879 |
| 132 | positive regulation of natural killer cell activation (GO:0032816) | 2.85719048 |
| 133 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.85282850 |
| 134 | maturation of SSU-rRNA (GO:0030490) | 2.83643650 |
| 135 | protein targeting to ER (GO:0045047) | 2.83617925 |
| 136 | replication fork processing (GO:0031297) | 2.83478699 |
| 137 | spindle assembly checkpoint (GO:0071173) | 2.83460259 |
| 138 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.83393226 |
| 139 | sister chromatid segregation (GO:0000819) | 2.82516563 |
| 140 | cellular response to virus (GO:0098586) | 2.82314193 |
| 141 | response to muramyl dipeptide (GO:0032495) | 2.82252205 |
| 142 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.82222616 |
| 143 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81801401 |
| 144 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.81284788 |
| 145 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.77979601 |
| 146 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.77214150 |
| 147 | single strand break repair (GO:0000012) | 2.76913605 |
| 148 | positive regulation of interleukin-17 production (GO:0032740) | 2.76823363 |
| 149 | regulation of natural killer cell activation (GO:0032814) | 2.74012212 |
| 150 | respiratory chain complex IV assembly (GO:0008535) | 2.73423717 |
| 151 | mitotic chromosome condensation (GO:0007076) | 2.73319872 |
| 152 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.73136581 |
| 153 | positive regulation of interferon-beta production (GO:0032728) | 2.72891848 |
| 154 | positive regulation of interleukin-12 production (GO:0032735) | 2.72595807 |
| 155 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.70688482 |
| 156 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.69325893 |
| 157 | DNA damage response, detection of DNA damage (GO:0042769) | 2.69294769 |
| 158 | regulation of chromosome segregation (GO:0051983) | 2.68934201 |
| 159 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.68804483 |
| 160 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.68746682 |
| 161 | neutrophil mediated immunity (GO:0002446) | 2.67771552 |
| 162 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65802570 |
| 163 | response to protozoan (GO:0001562) | 2.65668939 |
| 164 | regulation of hypersensitivity (GO:0002883) | 2.64690573 |
| 165 | myeloid dendritic cell activation (GO:0001773) | 2.63034605 |
| 166 | regulation of chemokine biosynthetic process (GO:0045073) | 2.60853157 |
| 167 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.60502625 |
| 168 | cellular response to interferon-alpha (GO:0035457) | 2.56975586 |
| 169 | myeloid dendritic cell differentiation (GO:0043011) | 2.56099803 |
| 170 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55926828 |
| 171 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.53153564 |
| 172 | positive regulation of T cell migration (GO:2000406) | 2.52873729 |
| 173 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.52151526 |
| 174 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50984584 |
| 175 | negative regulation of interleukin-17 production (GO:0032700) | 2.47210186 |
| 176 | natural killer cell differentiation (GO:0001779) | 2.46592804 |
| 177 | positive regulation of T cell chemotaxis (GO:0010820) | 2.46177297 |
| 178 | regulation of T cell chemotaxis (GO:0010819) | 2.46177297 |
| 179 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45300409 |
| 180 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.42559576 |
| 181 | regulation of defense response to virus by host (GO:0050691) | 2.42406107 |
| 182 | valine metabolic process (GO:0006573) | 2.41674402 |
| 183 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.41029029 |
| 184 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.39889862 |
| 185 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.39682659 |
| 186 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.39509951 |
| 187 | lymphocyte mediated immunity (GO:0002449) | 2.37488085 |
| 188 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.37435881 |
| 189 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.37126719 |
| 190 | defense response to virus (GO:0051607) | 2.36812067 |
| 191 | regulation of T cell migration (GO:2000404) | 2.36337571 |
| 192 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36232534 |
| 193 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36232534 |
| 194 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36232534 |
| 195 | modulation by symbiont of host immune response (GO:0052553) | 2.36232534 |
| 196 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36232534 |
| 197 | modulation by symbiont of host defense response (GO:0052031) | 2.36232534 |
| 198 | dendritic cell differentiation (GO:0097028) | 2.35919001 |
| 199 | regulation of interleukin-17 production (GO:0032660) | 2.35009349 |
| 200 | cell killing (GO:0001906) | 2.33471915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.95501845 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.77275188 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.95495087 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.28889739 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.96274331 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70684168 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.67568169 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.48178821 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.45742068 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.26121841 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.25858614 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.24715406 |
| 13 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.20723446 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10663594 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.08708470 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.02852007 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99200933 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.85478365 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.80763006 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.75765440 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73386092 |
| 22 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.71716747 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.67464229 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62708609 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62281317 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.56468912 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47018314 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43824222 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.42681038 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42351484 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40237910 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.39930393 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34080533 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.33699540 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31295321 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27541186 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27280834 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.25596491 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18258480 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.18086497 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15923509 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.15368152 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14486738 |
| 44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.11096669 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.06951677 |
| 46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05632095 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.04585032 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.02839070 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.00455166 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.99240580 |
| 51 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.93253345 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92519585 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90199233 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87912970 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.85634460 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.82384541 |
| 57 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79958709 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.71394712 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69762394 |
| 60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69460526 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.69378259 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67822288 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66972504 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.64896086 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63762936 |
| 66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.63456878 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55905684 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55026629 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.53893219 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.53830276 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.53124365 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51390157 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51086953 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.49593682 |
| 75 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49228901 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47612683 |
| 77 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46115809 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45353450 |
| 79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44967362 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41078323 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38944582 |
| 82 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37266431 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36134929 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34951341 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34808739 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34040535 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33032551 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32907337 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.32359792 |
| 90 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31345145 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31023188 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30677923 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25651395 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 1.23830471 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23683151 |
| 96 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23680934 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23310540 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23076507 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22385609 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22191505 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18021028 |
| 102 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.16993140 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16619315 |
| 104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16109467 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15750255 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.15146629 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12064937 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11040328 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09608864 |
| 110 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09077256 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08994484 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08693609 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08419309 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08419309 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08071941 |
| 116 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07754729 |
| 117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07409189 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07177055 |
| 119 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.07146366 |
| 120 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.07146366 |
| 121 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.07146366 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06791816 |
| 123 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06620420 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06390410 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05852888 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04035171 |
| 127 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03591551 |
| 128 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03574426 |
| 129 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03499514 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02888451 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01776461 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01764274 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01713132 |
| 134 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01690968 |
| 135 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01179473 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00962357 |
| 137 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00352965 |
| 138 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.97813980 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97761518 |
| 140 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97593828 |
| 141 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97553296 |
| 142 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97494114 |
| 143 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97074431 |
| 144 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.96732680 |
| 145 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95598140 |
| 146 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95057012 |
| 147 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.94876445 |
| 148 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94803501 |
| 149 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93069668 |
| 150 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92919669 |
| 151 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.91769354 |
| 152 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91714410 |
| 153 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.91278166 |
| 154 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91039603 |
| 155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89788209 |
| 156 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.89115874 |
| 157 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.87707931 |
| 158 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87363961 |
| 159 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.86768055 |
| 160 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86690017 |
| 161 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.86147536 |
| 162 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85972638 |
| 163 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.85680406 |
| 164 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85523654 |
| 165 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84174305 |
| 166 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82235273 |
| 167 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81313794 |
| 168 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80778534 |
| 169 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80261770 |
| 170 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.79531345 |
| 171 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.79125753 |
| 172 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78740312 |
| 173 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78522350 |
| 174 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78331534 |
| 175 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77598157 |
| 176 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77563855 |
| 177 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77547969 |
| 178 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76608885 |
| 179 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76569969 |
| 180 | * P68_20966046_ChIP-Seq_HELA_Human | 0.76533808 |
| 181 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75879961 |
| 182 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.75319156 |
| 183 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.74099939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.90778865 |
| 2 | MP0008058_abnormal_DNA_repair | 4.36319378 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.24868442 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.97874937 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.72875387 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.57375874 |
| 7 | MP0003718_maternal_effect | 3.47991652 |
| 8 | MP0009785_altered_susceptibility_to | 3.33288148 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 3.19613941 |
| 10 | MP0003077_abnormal_cell_cycle | 3.13457381 |
| 11 | MP0003136_yellow_coat_color | 2.93395104 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.93016027 |
| 13 | MP0003436_decreased_susceptibility_to | 2.83957426 |
| 14 | MP0008932_abnormal_embryonic_tissue | 2.75915274 |
| 15 | MP0003941_abnormal_skin_development | 2.60477025 |
| 16 | MP0000685_abnormal_immune_system | 2.55940339 |
| 17 | MP0005025_abnormal_response_to | 2.55061411 |
| 18 | MP0002419_abnormal_innate_immunity | 2.44199700 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.40417835 |
| 20 | MP0008057_abnormal_DNA_replication | 2.35996013 |
| 21 | MP0005671_abnormal_response_to | 2.35496363 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.35302799 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.29972569 |
| 24 | MP0006292_abnormal_olfactory_placode | 2.21791712 |
| 25 | MP0005387_immune_system_phenotype | 2.18872037 |
| 26 | MP0001790_abnormal_immune_system | 2.18872037 |
| 27 | MP0003724_increased_susceptibility_to | 2.17690918 |
| 28 | MP0005310_abnormal_salivary_gland | 2.16758409 |
| 29 | MP0006082_CNS_inflammation | 2.16237371 |
| 30 | MP0002006_tumorigenesis | 2.13821064 |
| 31 | MP0003786_premature_aging | 2.07458904 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.99668131 |
| 33 | MP0004947_skin_inflammation | 1.99045901 |
| 34 | MP0002723_abnormal_immune_serum | 1.96374970 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.92588341 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.91784488 |
| 37 | MP0003186_abnormal_redox_activity | 1.88349026 |
| 38 | MP0001853_heart_inflammation | 1.87081743 |
| 39 | MP0001800_abnormal_humoral_immune | 1.83895377 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.82840443 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.75012095 |
| 42 | MP0001819_abnormal_immune_cell | 1.74412580 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.73245104 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.70293607 |
| 45 | MP0002254_reproductive_system_inflammat | 1.70032286 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.69365500 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.68634651 |
| 48 | MP0009840_abnormal_foam_cell | 1.66975230 |
| 49 | MP0005410_abnormal_fertilization | 1.66844536 |
| 50 | MP0005501_abnormal_skin_physiology | 1.66705761 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.63660102 |
| 52 | MP0001929_abnormal_gametogenesis | 1.63112793 |
| 53 | MP0005451_abnormal_body_composition | 1.62055099 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.61268030 |
| 55 | MP0009764_decreased_sensitivity_to | 1.60398928 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.60149109 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.58928468 |
| 58 | MP0000579_abnormal_nail_morphology | 1.58840073 |
| 59 | MP0003303_peritoneal_inflammation | 1.57715943 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.57063805 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.56511901 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.55125513 |
| 63 | MP0001873_stomach_inflammation | 1.53569618 |
| 64 | MP0008469_abnormal_protein_level | 1.51616729 |
| 65 | MP0001730_embryonic_growth_arrest | 1.47712362 |
| 66 | MP0002405_respiratory_system_inflammati | 1.47367577 |
| 67 | MP0001293_anophthalmia | 1.43802717 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.40808565 |
| 69 | MP0002210_abnormal_sex_determination | 1.39819034 |
| 70 | MP0009697_abnormal_copulation | 1.34004373 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.33746894 |
| 72 | MP0000858_altered_metastatic_potential | 1.33677531 |
| 73 | MP0000343_altered_response_to | 1.33609296 |
| 74 | MP0003448_altered_tumor_morphology | 1.33308964 |
| 75 | MP0000313_abnormal_cell_death | 1.30140648 |
| 76 | MP0002653_abnormal_ependyma_morphology | 1.29545056 |
| 77 | MP0003698_abnormal_male_reproductive | 1.27062813 |
| 78 | MP0000716_abnormal_immune_system | 1.26866611 |
| 79 | MP0001346_abnormal_lacrimal_gland | 1.26466088 |
| 80 | MP0009672_abnormal_birth_weight | 1.25514653 |
| 81 | MP0003119_abnormal_digestive_system | 1.24728590 |
| 82 | MP0008995_early_reproductive_senescence | 1.24225239 |
| 83 | MP0005380_embryogenesis_phenotype | 1.23439126 |
| 84 | MP0001672_abnormal_embryogenesis/_devel | 1.23439126 |
| 85 | MP0000653_abnormal_sex_gland | 1.22044852 |
| 86 | MP0001145_abnormal_male_reproductive | 1.20714249 |
| 87 | MP0001697_abnormal_embryo_size | 1.20384980 |
| 88 | MP0001666_abnormal_nutrient_absorption | 1.18477472 |
| 89 | MP0004510_myositis | 1.18388893 |
| 90 | MP0002080_prenatal_lethality | 1.17170438 |
| 91 | MP0005360_urolithiasis | 1.16016761 |
| 92 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15046004 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 1.13457395 |
| 94 | MP0002938_white_spotting | 1.13314056 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 1.10881225 |
| 96 | MP0002396_abnormal_hematopoietic_system | 1.09144966 |
| 97 | MP0000566_synostosis | 1.08958061 |
| 98 | MP0002398_abnormal_bone_marrow | 1.08482288 |
| 99 | MP0005395_other_phenotype | 1.08227536 |
| 100 | MP0000516_abnormal_urinary_system | 1.07844392 |
| 101 | MP0005367_renal/urinary_system_phenotyp | 1.07844392 |
| 102 | MP0001545_abnormal_hematopoietic_system | 1.07589752 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 1.07589752 |
| 104 | MP0001188_hyperpigmentation | 1.06242803 |
| 105 | MP0002085_abnormal_embryonic_tissue | 1.05586682 |
| 106 | MP0000678_abnormal_parathyroid_gland | 1.04940778 |
| 107 | MP0005408_hypopigmentation | 1.04610570 |
| 108 | MP0002796_impaired_skin_barrier | 1.03935937 |
| 109 | MP0003075_altered_response_to | 1.03434659 |
| 110 | MP0000604_amyloidosis | 1.02845566 |
| 111 | MP0002234_abnormal_pharynx_morphology | 1.02202330 |
| 112 | MP0003300_gastrointestinal_ulcer | 1.02098676 |
| 113 | MP0002098_abnormal_vibrissa_morphology | 1.01887096 |
| 114 | MP0009763_increased_sensitivity_to | 1.00880848 |
| 115 | MP0002429_abnormal_blood_cell | 1.00238091 |
| 116 | MP0001881_abnormal_mammary_gland | 1.00031543 |
| 117 | MP0003984_embryonic_growth_retardation | 0.99534874 |
| 118 | MP0002009_preneoplasia | 0.97432614 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.97101897 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.95957580 |
| 121 | MP0000358_abnormal_cell_content/ | 0.95800064 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.95523990 |
| 123 | MP0002132_abnormal_respiratory_system | 0.95511855 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.95103067 |
| 125 | MP0002088_abnormal_embryonic_growth/wei | 0.94551319 |
| 126 | MP0002019_abnormal_tumor_incidence | 0.94003072 |
| 127 | MP0002161_abnormal_fertility/fecundity | 0.93448330 |
| 128 | MP0005394_taste/olfaction_phenotype | 0.93149558 |
| 129 | MP0005499_abnormal_olfactory_system | 0.93149558 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.92802567 |
| 131 | MP0004133_heterotaxia | 0.92531497 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.91006976 |
| 133 | MP0004381_abnormal_hair_follicle | 0.90822845 |
| 134 | MP0002084_abnormal_developmental_patter | 0.89532707 |
| 135 | MP0002722_abnormal_immune_system | 0.88258922 |
| 136 | MP0003315_abnormal_perineum_morphology | 0.87764652 |
| 137 | MP0001119_abnormal_female_reproductive | 0.87634493 |
| 138 | MP0005166_decreased_susceptibility_to | 0.86665036 |
| 139 | MP0010307_abnormal_tumor_latency | 0.85857133 |
| 140 | MP0005332_abnormal_amino_acid | 0.85839414 |
| 141 | MP0005075_abnormal_melanosome_morpholog | 0.85802295 |
| 142 | MP0005174_abnormal_tail_pigmentation | 0.85528996 |
| 143 | MP0005319_abnormal_enzyme/_coenzyme | 0.85462750 |
| 144 | MP0000490_abnormal_crypts_of | 0.84638663 |
| 145 | MP0001851_eye_inflammation | 0.84349340 |
| 146 | MP0003195_calcinosis | 0.83004098 |
| 147 | MP0003828_pulmonary_edema | 0.82748757 |
| 148 | MP0000377_abnormal_hair_follicle | 0.82677592 |
| 149 | MP0003699_abnormal_female_reproductive | 0.82389410 |
| 150 | MP0005085_abnormal_gallbladder_physiolo | 0.81361134 |
| 151 | MP0005365_abnormal_bile_salt | 0.80399867 |
| 152 | MP0002998_abnormal_bone_remodeling | 0.80168783 |
| 153 | MP0005084_abnormal_gallbladder_morpholo | 0.79966691 |
| 154 | MP0004019_abnormal_vitamin_homeostasis | 0.79966557 |
| 155 | MP0006054_spinal_hemorrhage | 0.79166791 |
| 156 | MP0005275_abnormal_skin_tensile | 0.78997909 |
| 157 | MP0002111_abnormal_tail_morphology | 0.78180388 |
| 158 | MP0004197_abnormal_fetal_growth/weight/ | 0.77108184 |
| 159 | MP0009643_abnormal_urine_homeostasis | 0.76776635 |
| 160 | MP0009278_abnormal_bone_marrow | 0.76542891 |
| 161 | MP0002136_abnormal_kidney_physiology | 0.75873545 |
| 162 | MP0003763_abnormal_thymus_physiology | 0.75758957 |
| 163 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75362607 |
| 164 | MP0003705_abnormal_hypodermis_morpholog | 0.75354625 |
| 165 | MP0000383_abnormal_hair_follicle | 0.74690437 |
| 166 | MP0000465_gastrointestinal_hemorrhage | 0.73888987 |
| 167 | MP0005164_abnormal_response_to | 0.73600631 |
| 168 | MP0002282_abnormal_trachea_morphology | 0.73504692 |
| 169 | MP0003566_abnormal_cell_adhesion | 0.72792388 |
| 170 | MP0000537_abnormal_urethra_morphology | 0.72364230 |
| 171 | MP0000609_abnormal_liver_physiology | 0.72082701 |
| 172 | MP0005390_skeleton_phenotype | 0.71365890 |
| 173 | MP0003806_abnormal_nucleotide_metabolis | 0.70815048 |
| 174 | MP0001764_abnormal_homeostasis | 0.69291161 |
| 175 | MP0005670_abnormal_white_adipose | 0.68632723 |
| 176 | MP0002249_abnormal_larynx_morphology | 0.68572296 |
| 177 | MP0010386_abnormal_urinary_bladder | 0.68417723 |
| 178 | MP0002139_abnormal_hepatobiliary_system | 0.68167369 |
| 179 | MP0005647_abnormal_sex_gland | 0.68124129 |
| 180 | MP0001286_abnormal_eye_development | 0.68035198 |
| 181 | MP0003866_abnormal_defecation | 0.67107368 |
| 182 | MP0002933_joint_inflammation | 0.66258697 |
| 183 | MP0000613_abnormal_salivary_gland | 0.65683587 |
| 184 | MP0005645_abnormal_hypothalamus_physiol | 0.63430165 |
| 185 | MP0003011_delayed_dark_adaptation | 0.63222792 |
| 186 | MP0005377_hearing/vestibular/ear_phenot | 0.60496926 |
| 187 | MP0003878_abnormal_ear_physiology | 0.60496926 |
| 188 | MP0001529_abnormal_vocalization | 0.60113130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.90715733 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.86885841 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.56660534 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.95157149 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.79923605 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.47192143 |
| 7 | Abnormality of the labia minora (HP:0012880) | 3.92845596 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87061545 |
| 9 | Recurrent skin infections (HP:0001581) | 3.62995014 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.44572828 |
| 11 | Acute encephalopathy (HP:0006846) | 3.40199173 |
| 12 | Chronic otitis media (HP:0000389) | 3.37323163 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.32254029 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.27506989 |
| 15 | Colon cancer (HP:0003003) | 3.27066429 |
| 16 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.26055809 |
| 17 | Increased IgM level (HP:0003496) | 3.23306644 |
| 18 | Pustule (HP:0200039) | 3.22886272 |
| 19 | Hypergammaglobulinemia (HP:0010702) | 3.16424178 |
| 20 | Abnormality of glycolysis (HP:0004366) | 3.16358569 |
| 21 | Hepatocellular necrosis (HP:0001404) | 3.13861397 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10461641 |
| 23 | Increased IgE level (HP:0003212) | 3.06836321 |
| 24 | Mitochondrial inheritance (HP:0001427) | 3.06257254 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 3.05917633 |
| 26 | Chromsome breakage (HP:0040012) | 3.03881973 |
| 27 | Increased serum pyruvate (HP:0003542) | 3.02908044 |
| 28 | Recurrent fungal infections (HP:0002841) | 2.99312297 |
| 29 | Thrombocytosis (HP:0001894) | 2.95835352 |
| 30 | Gingivitis (HP:0000230) | 2.94493784 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.91681458 |
| 32 | Periodontitis (HP:0000704) | 2.90631130 |
| 33 | Increased CSF lactate (HP:0002490) | 2.86690292 |
| 34 | Myositis (HP:0100614) | 2.86050349 |
| 35 | Vasculitis (HP:0002633) | 2.85812265 |
| 36 | Urticaria (HP:0001025) | 2.85508420 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 2.85222272 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.84321344 |
| 39 | Hyperglycinemia (HP:0002154) | 2.84215427 |
| 40 | Abnormality of the preputium (HP:0100587) | 2.83394645 |
| 41 | Recurrent viral infections (HP:0004429) | 2.83228025 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.74718844 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74304089 |
| 44 | Obstructive lung disease (HP:0006536) | 2.74304089 |
| 45 | Microvesicular hepatic steatosis (HP:0001414) | 2.69608726 |
| 46 | Axonal loss (HP:0003447) | 2.69490422 |
| 47 | Thick nail (HP:0001805) | 2.69331927 |
| 48 | Testicular atrophy (HP:0000029) | 2.68813000 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.68597711 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.68597711 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.67923055 |
| 52 | Hepatic necrosis (HP:0002605) | 2.66033033 |
| 53 | Abnormal number of erythroid precursors (HP:0012131) | 2.65640466 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.64991047 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.64533989 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.64187270 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.63775987 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.62981864 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.59959638 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.59959638 |
| 61 | Meckel diverticulum (HP:0002245) | 2.59764478 |
| 62 | Prostate neoplasm (HP:0100787) | 2.58969736 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.57863577 |
| 64 | Petechiae (HP:0000967) | 2.57442074 |
| 65 | Hyperglycinuria (HP:0003108) | 2.57239711 |
| 66 | Multiple enchondromatosis (HP:0005701) | 2.55837730 |
| 67 | Cerebral edema (HP:0002181) | 2.49376261 |
| 68 | Macrocytic anemia (HP:0001972) | 2.45351982 |
| 69 | Pili torti (HP:0003777) | 2.43686905 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 2.39781530 |
| 71 | Abnormal glycosylation (HP:0012345) | 2.39781530 |
| 72 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39781530 |
| 73 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.39781530 |
| 74 | Abnormal lung lobation (HP:0002101) | 2.39118160 |
| 75 | Increased serum lactate (HP:0002151) | 2.38418338 |
| 76 | Abnormality of the ileum (HP:0001549) | 2.37720032 |
| 77 | Progressive macrocephaly (HP:0004481) | 2.37136917 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 2.34655167 |
| 79 | Prolonged neonatal jaundice (HP:0006579) | 2.33792211 |
| 80 | Poor head control (HP:0002421) | 2.33669119 |
| 81 | Orchitis (HP:0100796) | 2.32663535 |
| 82 | Duodenal stenosis (HP:0100867) | 2.32635702 |
| 83 | Small intestinal stenosis (HP:0012848) | 2.32635702 |
| 84 | Myocardial infarction (HP:0001658) | 2.30879809 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.30350426 |
| 86 | Lactic acidosis (HP:0003128) | 2.30120795 |
| 87 | Loss of speech (HP:0002371) | 2.29871093 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26611700 |
| 89 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.25944204 |
| 90 | Eosinophilia (HP:0001880) | 2.23738968 |
| 91 | Nasal polyposis (HP:0100582) | 2.20218494 |
| 92 | Exercise intolerance (HP:0003546) | 2.19854383 |
| 93 | Gingival bleeding (HP:0000225) | 2.19479121 |
| 94 | Myelodysplasia (HP:0002863) | 2.19008264 |
| 95 | Respiratory difficulties (HP:0002880) | 2.17138901 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.17085505 |
| 97 | Tetraparesis (HP:0002273) | 2.16979211 |
| 98 | Steatorrhea (HP:0002570) | 2.16737899 |
| 99 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.12075755 |
| 100 | Prolonged partial thromboplastin time (HP:0003645) | 2.11949693 |
| 101 | Cellulitis (HP:0100658) | 2.10038555 |
| 102 | Abnormality of chromosome stability (HP:0003220) | 2.09255793 |
| 103 | Oral leukoplakia (HP:0002745) | 2.09110371 |
| 104 | Abnormality of serum amino acid levels (HP:0003112) | 2.08551911 |
| 105 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.08486353 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.08388817 |
| 107 | Impulsivity (HP:0100710) | 2.07577403 |
| 108 | Abnormality of the nasal mucosa (HP:0000433) | 2.06941784 |
| 109 | Methylmalonic aciduria (HP:0012120) | 2.05835440 |
| 110 | Lethargy (HP:0001254) | 2.04980290 |
| 111 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04749780 |
| 112 | Leukocytosis (HP:0001974) | 2.04390814 |
| 113 | Abnormality of the duodenum (HP:0002246) | 2.04374691 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04272799 |
| 115 | Cholecystitis (HP:0001082) | 2.03796987 |
| 116 | Abnormal gallbladder physiology (HP:0012438) | 2.03796987 |
| 117 | Granulocytopenia (HP:0001913) | 2.03496361 |
| 118 | Stomatitis (HP:0010280) | 2.03076109 |
| 119 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02795962 |
| 120 | Abnormality of the prostate (HP:0008775) | 2.02619421 |
| 121 | Mucopolysacchariduria (HP:0008155) | 2.01230185 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01230185 |
| 123 | Recurrent pneumonia (HP:0006532) | 2.00221670 |
| 124 | Absent thumb (HP:0009777) | 1.99883293 |
| 125 | Rough bone trabeculation (HP:0100670) | 1.99851290 |
| 126 | Skin ulcer (HP:0200042) | 1.99815515 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99744240 |
| 128 | Exertional dyspnea (HP:0002875) | 1.99721332 |
| 129 | Sloping forehead (HP:0000340) | 1.99352022 |
| 130 | Cerebral hypomyelination (HP:0006808) | 1.97529048 |
| 131 | Methylmalonic acidemia (HP:0002912) | 1.96150554 |
| 132 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.96113273 |
| 133 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95864772 |
| 134 | Absent radius (HP:0003974) | 1.95037279 |
| 135 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.94175089 |
| 136 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.94175089 |
| 137 | Hemoptysis (HP:0002105) | 1.94126325 |
| 138 | Septo-optic dysplasia (HP:0100842) | 1.93980835 |
| 139 | Pulmonary infiltrates (HP:0002113) | 1.93920733 |
| 140 | Nausea (HP:0002018) | 1.92890551 |
| 141 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.92559049 |
| 142 | Postnatal microcephaly (HP:0005484) | 1.92245430 |
| 143 | Albinism (HP:0001022) | 1.92166105 |
| 144 | Optic neuritis (HP:0100653) | 1.91247795 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.91247795 |
| 146 | Increased muscle lipid content (HP:0009058) | 1.91160123 |
| 147 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.90976226 |
| 148 | Esophageal varix (HP:0002040) | 1.90918209 |
| 149 | Triphalangeal thumb (HP:0001199) | 1.90366419 |
| 150 | Premature ovarian failure (HP:0008209) | 1.90138080 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.88916167 |
| 152 | Horseshoe kidney (HP:0000085) | 1.87494439 |
| 153 | Osteomyelitis (HP:0002754) | 1.86838990 |
| 154 | Pallor (HP:0000980) | 1.86503345 |
| 155 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86143118 |
| 156 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86143118 |
| 157 | Pancytopenia (HP:0001876) | 1.86030448 |
| 158 | Abnormal trabecular bone morphology (HP:0100671) | 1.85283577 |
| 159 | Erythroderma (HP:0001019) | 1.85281715 |
| 160 | Neutropenia (HP:0001875) | 1.85100656 |
| 161 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.85063399 |
| 162 | Dysostosis multiplex (HP:0000943) | 1.84573976 |
| 163 | Respiratory failure (HP:0002878) | 1.84330014 |
| 164 | Megaloblastic anemia (HP:0001889) | 1.82519627 |
| 165 | Ependymoma (HP:0002888) | 1.82490753 |
| 166 | Anhidrosis (HP:0000970) | 1.81728245 |
| 167 | Amniotic constriction ring (HP:0009775) | 1.81710635 |
| 168 | Abnormality of placental membranes (HP:0011409) | 1.81710635 |
| 169 | Reticulocytopenia (HP:0001896) | 1.81527923 |
| 170 | Abnormal hair laboratory examination (HP:0003328) | 1.81092539 |
| 171 | Absent forearm bone (HP:0003953) | 1.80821850 |
| 172 | Aplasia involving forearm bones (HP:0009822) | 1.80821850 |
| 173 | Anorexia (HP:0002039) | 1.79031766 |
| 174 | Hypoplastic pelvis (HP:0008839) | 1.77985654 |
| 175 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76837821 |
| 176 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76837821 |
| 177 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76837821 |
| 178 | Parakeratosis (HP:0001036) | 1.75977498 |
| 179 | Gangrene (HP:0100758) | 1.75761938 |
| 180 | Premature loss of primary teeth (HP:0006323) | 1.75385283 |
| 181 | Erythema (HP:0010783) | 1.74365016 |
| 182 | Hematochezia (HP:0002573) | 1.73996574 |
| 183 | Cheilitis (HP:0100825) | 1.73765175 |
| 184 | Abnormal hair whorl (HP:0010721) | 1.73625148 |
| 185 | Squamous cell carcinoma (HP:0002860) | 1.73153794 |
| 186 | Sparse eyelashes (HP:0000653) | 1.72526150 |
| 187 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72388169 |
| 188 | Dicarboxylic aciduria (HP:0003215) | 1.72388169 |
| 189 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70084410 |
| 190 | Progressive visual loss (HP:0000529) | 1.70001270 |
| 191 | Meningitis (HP:0001287) | 1.69806622 |
| 192 | Epistaxis (HP:0000421) | 1.69743777 |
| 193 | Joint hemorrhage (HP:0005261) | 1.69575344 |
| 194 | Polyneuropathy (HP:0001271) | 1.69028360 |
| 195 | Abnormality of T cell number (HP:0011839) | 1.68744398 |
| 196 | Reduced antithrombin III activity (HP:0001976) | 1.68143319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.56705580 |
| 2 | VRK2 | 5.37358789 |
| 3 | MAP3K14 | 3.56904737 |
| 4 | TTK | 3.36318557 |
| 5 | PBK | 3.13225254 |
| 6 | TBK1 | 3.09405402 |
| 7 | CDC7 | 2.97024656 |
| 8 | MST4 | 2.90791716 |
| 9 | TYK2 | 2.84354420 |
| 10 | NEK1 | 2.72014292 |
| 11 | TSSK6 | 2.71061785 |
| 12 | NME1 | 2.56015369 |
| 13 | SRPK1 | 2.50897473 |
| 14 | TAF1 | 2.49714287 |
| 15 | IRAK4 | 2.45113574 |
| 16 | IKBKE | 2.40662073 |
| 17 | PIM2 | 2.38803206 |
| 18 | BLK | 2.32060503 |
| 19 | VRK1 | 2.31384228 |
| 20 | ERN1 | 2.30726494 |
| 21 | ZAK | 2.30657781 |
| 22 | IKBKB | 2.29244138 |
| 23 | RIPK4 | 2.28289768 |
| 24 | IRAK3 | 2.23513669 |
| 25 | NME2 | 2.20960337 |
| 26 | PLK4 | 2.15870027 |
| 27 | PLK3 | 2.15458862 |
| 28 | JAK3 | 2.13750924 |
| 29 | SMG1 | 2.12461761 |
| 30 | BRSK2 | 1.95872826 |
| 31 | STK39 | 1.91483492 |
| 32 | TAOK3 | 1.84105366 |
| 33 | BCKDK | 1.77181900 |
| 34 | EPHB1 | 1.77042350 |
| 35 | PLK1 | 1.73724231 |
| 36 | BRSK1 | 1.71847162 |
| 37 | KIT | 1.66890102 |
| 38 | NEK9 | 1.62458375 |
| 39 | MAPK15 | 1.59712213 |
| 40 | MKNK1 | 1.57689679 |
| 41 | TRPM7 | 1.57126876 |
| 42 | RPS6KA4 | 1.52504870 |
| 43 | MKNK2 | 1.47291369 |
| 44 | BTK | 1.46576438 |
| 45 | CHEK2 | 1.42526338 |
| 46 | WEE1 | 1.42374916 |
| 47 | MAP4K2 | 1.41216878 |
| 48 | CDK7 | 1.39642860 |
| 49 | TESK1 | 1.38092412 |
| 50 | MAP4K1 | 1.38072416 |
| 51 | LRRK2 | 1.33109312 |
| 52 | NEK2 | 1.30990450 |
| 53 | BMPR1B | 1.30898599 |
| 54 | JAK1 | 1.30650052 |
| 55 | ATR | 1.28244560 |
| 56 | MAP2K3 | 1.26990119 |
| 57 | CHUK | 1.25777846 |
| 58 | STK10 | 1.25117039 |
| 59 | EIF2AK3 | 1.24411905 |
| 60 | MST1R | 1.22522965 |
| 61 | STK4 | 1.22502239 |
| 62 | MUSK | 1.20681136 |
| 63 | CSF1R | 1.18030292 |
| 64 | PIK3CG | 1.16927318 |
| 65 | FLT3 | 1.16679734 |
| 66 | DYRK2 | 1.15195006 |
| 67 | CDK19 | 1.13149401 |
| 68 | ACVR1B | 1.10808109 |
| 69 | AURKB | 1.10075997 |
| 70 | EIF2AK1 | 1.09781474 |
| 71 | EIF2AK2 | 1.06695937 |
| 72 | TEC | 1.06511111 |
| 73 | ZAP70 | 1.06175965 |
| 74 | ABL2 | 1.02443111 |
| 75 | STK3 | 0.98585088 |
| 76 | MAP3K3 | 0.97827841 |
| 77 | MAP3K13 | 0.97500382 |
| 78 | SYK | 0.94576389 |
| 79 | AURKA | 0.94551986 |
| 80 | TRIM28 | 0.92982124 |
| 81 | TLK1 | 0.89909654 |
| 82 | PASK | 0.89202108 |
| 83 | TXK | 0.86158502 |
| 84 | EPHA2 | 0.85764763 |
| 85 | FGFR4 | 0.84424414 |
| 86 | AKT3 | 0.83409312 |
| 87 | TESK2 | 0.81981230 |
| 88 | MYLK | 0.81957349 |
| 89 | DAPK1 | 0.80155619 |
| 90 | CDK8 | 0.79370137 |
| 91 | STK24 | 0.79278820 |
| 92 | PIM1 | 0.78331682 |
| 93 | ERBB3 | 0.77210593 |
| 94 | LCK | 0.76383314 |
| 95 | WNK3 | 0.76197769 |
| 96 | JAK2 | 0.75234231 |
| 97 | BMPR2 | 0.74609112 |
| 98 | RPS6KB2 | 0.73779496 |
| 99 | CHEK1 | 0.71363763 |
| 100 | ARAF | 0.69341696 |
| 101 | CSK | 0.68674023 |
| 102 | ATM | 0.68312896 |
| 103 | NUAK1 | 0.67527694 |
| 104 | PRKCI | 0.67217683 |
| 105 | MELK | 0.66486211 |
| 106 | LYN | 0.66426274 |
| 107 | SIK1 | 0.65506797 |
| 108 | MAPKAPK2 | 0.64878957 |
| 109 | TTN | 0.64242793 |
| 110 | MAP3K11 | 0.64104768 |
| 111 | MAPKAPK3 | 0.64102997 |
| 112 | PTK6 | 0.62087191 |
| 113 | CDK9 | 0.59729035 |
| 114 | CSNK2A1 | 0.59128596 |
| 115 | TAOK2 | 0.58160890 |
| 116 | CLK1 | 0.57663498 |
| 117 | MAP2K2 | 0.56072105 |
| 118 | MET | 0.55769455 |
| 119 | CSNK1G1 | 0.55571809 |
| 120 | CSNK2A2 | 0.55397213 |
| 121 | CDK4 | 0.55369668 |
| 122 | BCR | 0.54943014 |
| 123 | MAP3K8 | 0.54433612 |
| 124 | DYRK3 | 0.53672299 |
| 125 | TNK2 | 0.53469257 |
| 126 | BMX | 0.53464655 |
| 127 | RPS6KA6 | 0.52856940 |
| 128 | PRKCQ | 0.52821257 |
| 129 | PRKCD | 0.52028544 |
| 130 | CSNK1G3 | 0.51621478 |
| 131 | EPHA3 | 0.51210156 |
| 132 | HCK | 0.51052053 |
| 133 | PAK4 | 0.50958360 |
| 134 | ABL1 | 0.50952844 |
| 135 | TNIK | 0.49826391 |
| 136 | IRAK1 | 0.48809933 |
| 137 | CDK2 | 0.48119185 |
| 138 | LMTK2 | 0.47410715 |
| 139 | BRAF | 0.47003814 |
| 140 | NLK | 0.46061304 |
| 141 | CDK1 | 0.44587032 |
| 142 | ALK | 0.44454375 |
| 143 | NEK6 | 0.44352749 |
| 144 | OXSR1 | 0.42508124 |
| 145 | MATK | 0.42357787 |
| 146 | MAPKAPK5 | 0.41441813 |
| 147 | RPS6KA5 | 0.40768768 |
| 148 | GRK1 | 0.40263693 |
| 149 | KDR | 0.39780760 |
| 150 | TGFBR1 | 0.39163412 |
| 151 | RPS6KC1 | 0.38579288 |
| 152 | RPS6KL1 | 0.38579288 |
| 153 | SCYL2 | 0.38217000 |
| 154 | ITK | 0.37980811 |
| 155 | PKN2 | 0.37146652 |
| 156 | TGFBR2 | 0.36150790 |
| 157 | STK16 | 0.35085514 |
| 158 | PDK2 | 0.34659016 |
| 159 | RPS6KA1 | 0.33907948 |
| 160 | CCNB1 | 0.30948312 |
| 161 | CSNK1E | 0.28602955 |
| 162 | MARK3 | 0.28465860 |
| 163 | PAK1 | 0.27813992 |
| 164 | MAP3K10 | 0.27482806 |
| 165 | AKT2 | 0.26293219 |
| 166 | TIE1 | 0.25179388 |
| 167 | WNK4 | 0.24800814 |
| 168 | CDK3 | 0.24527861 |
| 169 | FGFR1 | 0.24264381 |
| 170 | PRKDC | 0.22761098 |
| 171 | CSNK1A1L | 0.22371814 |
| 172 | CSNK1G2 | 0.22226136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.71326547 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.25888488 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.05892360 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.00897578 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.54839048 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52888410 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.48678139 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.46790143 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.40404910 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.34956376 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29554939 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.26537781 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.25998178 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24279500 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.04891569 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04803646 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.03912682 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.01075097 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94549718 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.91843758 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.89361883 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89358751 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87349025 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.87319991 |
| 25 | RNA transport_Homo sapiens_hsa03013 | 1.85581568 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.83782226 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83419228 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.82673661 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.82141082 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79222236 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.77164874 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76616327 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.75347404 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.73155118 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.69452603 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.69255677 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68642885 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.65763206 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.61249168 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60042534 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58188993 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51399937 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.47882203 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47344753 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46074550 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.45700127 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.41822111 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41292966 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39885373 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39592622 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39365102 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38745904 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 1.38278603 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.36725678 |
| 55 | Protein export_Homo sapiens_hsa03060 | 1.35750631 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 1.33790216 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 1.32836229 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.30268946 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29608229 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28823200 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28044336 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27717577 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.27165870 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 1.27039235 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22117560 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20652667 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19216558 |
| 68 | Purine metabolism_Homo sapiens_hsa00230 | 1.18735453 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 1.13245411 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12665599 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09905844 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09754574 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09129774 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06903848 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 1.06372157 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 1.04057482 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02168570 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01757110 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01651505 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.98928140 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97028708 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95845498 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94428482 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93939430 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92275834 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.91925448 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91677363 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90723789 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90685213 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90191191 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88797864 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88725083 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88546455 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.87771511 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85948290 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85561711 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83746819 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83571639 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83492201 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83115723 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82483461 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82100557 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78964895 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78253575 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77445196 |
| 106 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76654415 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75896852 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75657527 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71723567 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71534033 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71354795 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71196474 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70654723 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69721783 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68569813 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68491984 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.67686716 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67666711 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65778521 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65540617 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64006626 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63922745 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.63588092 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63434331 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62003959 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61295174 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57769384 |
| 128 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57663692 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.57481097 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56810785 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56541161 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56370422 |
| 133 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55337394 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54686997 |
| 135 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54179514 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53767456 |
| 137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53594147 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52820350 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51019958 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50962006 |
| 141 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50947961 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50770884 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48021259 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47591380 |
| 145 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47356562 |
| 146 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46940759 |
| 147 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46473134 |
| 148 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46000533 |
| 149 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45757187 |
| 150 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44257005 |
| 151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42163495 |
| 152 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41052058 |
| 153 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41039223 |
| 154 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40725101 |
| 155 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40284154 |
| 156 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39762276 |
| 157 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39156330 |
| 158 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37497179 |
| 159 | Lysine degradation_Homo sapiens_hsa00310 | 0.35204611 |
| 160 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33484025 |
| 161 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30483719 |
| 162 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26911966 |
| 163 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25574095 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24803340 |
| 165 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23845266 |

